Strong protective effect of the APOL1 p.N264K variant against G2-associated FSGS and kidney disease
Yask Gupta, David J. Friedman, Michelle T. McNulty, Atlas Khan, Brandon M. Lane, Chen Wang, Juntao Ke, Gina Ying Jin, Benjamin Wooden, Andrea L. Uscinski Knob, Tze Yin Lim, Gerald B. Appel, Kinsie Huggins, Lili Liu, Adele Mitrotti, , Simone Sanna‐Cherchi
The paper shows the APOL1 p.N264K variant reduces the risk of FSGS and kidney disease in individuals with G2 APOL1 risk alleles.
Nature Communications · Nov 30, 2023Peer-reviewedGenetic & Genomic Medicine